Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)
| 12.42 Delayed Data As of Aug 12 |  +0.25 / +2.06%Today’s Change | 7.36 Today|||52-Week Range 15.25 | +5.52% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 12.0K | 12.0K | 254.0K | 471.0K | ||
| Operating Expenses | Gross Income | -12.0K | -12.0K | -254.0K | -471.0K | |
| General Expenses | 21.5M | 26.1M | 43.9M | 67.2M | ||
| Research And Development | 17.2M | 20.6M | 36.1M | 59.3M | ||
| Total Operating Expenses | 21.5M | 26.2M | 44.1M | 67.6M | ||
| Non-Operating Expenses | Operating Income | -21.5M | -26.2M | -44.1M | -67.6M | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -20.5M | -24.5M | -42.4M | -65.8M | |
| Income Taxes | -202.0K | -131.0K | -172.0K | -17.0K | ||
| Net Income | -20.3M | -24.4M | -42.6M | -65.8M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 20.8M | 48.2M | 48.5M | 51.8M | |
| Shares To Calculate EPS Diluted | 20.8M | 48.2M | 48.5M | 51.8M | ||
| Earnings Per Share | EPS | -$0.97 | -$0.51 | -$0.88 | -$1.27 | |
| EPS Diluted | -$0.97 | -$0.51 | -$0.88 | -$1.27 | ||
